Sanara MedTech (SMTI) Current Deferred Revenue (2017 - 2018)
Sanara MedTech's (SMTI) quarterly Current Deferred Revenue came in at $10474.0 in Q4 2018, down 24.76% YoY from $13920.0 in Q4 2017, and down 13.73% on a QoQ basis from $12141.0 in Q3 2018.
Sanara MedTech (SMTI) Current Deferred Revenue (2017 - 2018) Analysis & Trends
Sanara MedTech (SMTI) has 2 years of Current Deferred Revenue data on file, last reported at $10474.0 in Q4 2018.
- Quarterly Current Deferred Revenue fell 24.76% year-over-year to $10474.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $10474.0 (down 24.76% YoY) and the FY2018 annual result came in at $10474.0, down 24.76% from the prior year.
- Current Deferred Revenue slipped to $10474.0 in Q4 2018, from $12141.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $13920.0 in Q4 2017 to a low of $10474.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Sanara MedTech | 297.82 Mn | 297.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 10,474.00 |
| Sep 30, 2018 | 12,141.00 |
| Jun 30, 2018 | 12,913.00 |
| Mar 31, 2018 | 13,703.00 |
| Dec 31, 2017 | 13,920.00 |